Here’s their press release on the subject
Tilray Brands Inc. (NASDAQ: TLRY) has announced that its medical unit, Tilray Medical, has finalized the first sales of medical marijuana in Malta. The company’s EU-GMP medicinal marijuana products are currently accessible in pharmacies in Malta, ensuring that patients have safe and dependable access to high-quality marijuana.
Tilray Medical finalizes first medical marijuana sale in Malta
Tilray’s Chief Strategy Officer and Head of International Business, Denise Faltischek, said, “As demand for cannabis continues to grow across Europe, we’re incredibly proud to partner with established and reliable distribution partners to supply new markets with high-quality medical cannabis which patients can rely on.”
Individuals in Malta can get medicinal marijuana prescriptions and a medicinal marijuana card from their family doctors. In addition, Malta’s Superintendent of Public Health issues medicinal marijuana cards.
Tilray has a history of being a trailblazer in creating EU GMP-certified, pharmaceutical-grade medicinal marijuana products accessible to patients in need worldwide and was the first to satisfactorily export cannabis products from North America and import medicinal marijuana products into the European Union in 2016.
Tilray is consolidating its global medical cannabis operations as demand increases
It is important to note that the company recently launched Tilray Medical as a global platform meant to unify its medical marijuana brands under a single mission, vision, and strategy. Under the consolidation plan, Canadians will have access to a wide variety of the company’s medical marijuana products and brand choices worldwide, including Aphria, Broken Coast, Symbios and Tilray. Tilray Medical’s global product portfolio includes GMP-Certified and high-quality oils, flowers, edibles, topicals, and vapes, but these are subject to regulatory approval.
Faltischek stated, “Tilray is the global leader in the advancement of cannabinoid-based medicine, with a focus on providing research-backed medical cannabis products to physicians, pharmacies, and patients. By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world.”
